A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.
Author: Christina Jewett
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}